Results of R0 surgery with D2 lymphadenectomy for the treatment of localised gastric cancer

Clinical and Translational Oncology

Volumn 11, Issue 3, 2009, Pages 178-182

  Díaz de Liaño, Álvaro ^a   Yárnoz, Concepción ^a   Artieda, Cristina ^a   Aguilar, Rubén ^b   Viana, Sherbourne ^c   Artajona, Alicia ^a   Ortiz, Héctor ^a  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

^b Hospital Militar Central   (Paraguay)

^c HOSPITAL DE CLÍNICAS   (Uruguay)

Author keywords

D2 lymphadenectomy; Morbidity; Mortality; R0 gastrectomy; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ANASTOMOSIS DEHISCENCE; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; ESOPHAGOJEJUNOSTOMY; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; SPAIN; STOMACH CANCER; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TOTAL STOMACH RESECTION; TREATMENT RESPONSE; AGED; METHODOLOGY; MORTALITY; PROSPECTIVE STUDY; STOMACH TUMOR;

AGED; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 65649106927     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/S12094-009-0335-9     Document Type: Article

References (30)

1. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354-362
2. Dicken BJ, Bigam DL, Cass C et al (2005) Gastric adenocarcinoma: Review and considerations for future directions. Ann Surg 241:27-39
3. Bonenkamp JJ, Hermans J, Sasako M et al (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340:908-914
4. Cuschieri A, Fayers P, Fielding J et al (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomized controlled surgical trial. The Surgical Cooperative Group. Lancet 347:995-999
5. Kodera Y, Sasako M, Yamamoto S et al (2005) Identification of risk factors for the development of complications following extended an superex-tended lymphadenectomies for gastric cancer. Br J Surg 92:1103-1109
6. Tsujinaka T, Sasako M, Yamamoto S et al (2007) Influence of overweight on surgical complications for gastric cancer: Results from a randomized control trial comparing D2 and Extended para-aortic D3 lymphadenectomy (JCOG 9501). Ann Surg Oncol 14:355-361
7. Enzinger PC, Beneditti JK, Meyerhard JA et al (2007) Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg 245:426-434
8. Díaz de Liaño A, Yárnoz C, Aguilar R et al (2008) Morbidity and mortality in gastrectomy with D2 lymph-adenectomy in a specialized unit. Cir Esp 83:18-23
9. Wittekind CH, Greene FL, Hutter RVP et al (eds) (2005) TNM atlas: illustrated guide to the TNM classification of malignant tumors, 5th Edn. Springer-Verlag, Heidelberg
10. D'Angelica M, Gonen M, Brennan MF et al (2004) Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240:808-816
11. Bozzetti F, Marubini E, Bonfanti G et al (1999) Subtotal versus total gastrectomy for gastric cancer. Five-year survival rates in a Multicenter Randomized Italian Trial. Ann Surg 230:170-178
12. Bozzetti F, Marubini E, Bonfanti G et al (1997) Total versus subtotal gastrectomy, surgical morbidity and mortality rates in a Multicenter Italian Randomized Trial. Ann Surg 226:613-620
13. Kappas AM, Roukos DH (2002) Quality of surgery determinant for the out come of patient with gastric cancer. Ann Surg Oncol 9:828-830
14. Degiuli M, Sasako M, Calgaro M et al (2004) Morbidity and mortality after D1 and D2 gastrectomy for cancer: Interim analysis of the Italian Gastric Cancer Study Group(IGCSG) Randomized Surgical Trial. Eur J Surg Oncol 30:303-308
15. Sasako M (1997) Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg 84:1567-1571
16. Zilberstein B, da Costa Martins B, Jacob CE (2004) Complications of gastrectomy with lymphadenectomy in gastric cancer. Gastric Cancer 7:254-259
17. Lewis WG, Edwards P, Barry JD et al (2002) D2 or not D2? The gastrectomy question. Gastric Cancer 5:29-34
18. Brennan MF (1999) Lymph-node dissection for gastric cancer. N Engl J Med 340:956-958
19. Sano T, Sasako M, Yamamoto S et al (2004) Gastric cancer surgery morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymph-adenectomy - Japan Clinical Oncology Group Study 9501. J Clin Oncol 22:2767-2773
20. Siewert JR, Böttcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study. Ann Surg 228:449-461
21. Hartgrink HH, Van de Velde CJ, Putter H et al (2004) Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial. J Clin Oncol 22:2069-2077
22. Martin RC 2nd, Jaques DP, Brennan MF, Karpeh M (2002) Extended local resection for advanced gastric cancer: Increased survival versus increased morbidity. Ann Surg 236:159-165
23. Csendes A, Burdiles P, Rojas J et al (2002) A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 131:401-407
24. Yonemura Y, Wu CC, Fukushima N et al (2006) Operative morbidity and mortality alter D2 and D4 extended dissection for advanced gastric cancer: A prospective randomized trial conducted by Asian surgeons. Hepatogastroenterology 53:389-394
25. Yoo CH, Noh SH, Shin DW et al (2000) Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236-242
26. Desai AM, Pareek M, Nightingale PG, Fielding JW (2004) Improving outcomes in gastric cancer over 20 years. Gastric Cancer 7:196-203
27. Roukos D, Lorentz M, Encke A (1998) Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: A prospective long-term follow-up study. Surgery 123:573-578
28. Roukos D, Paraschou P (2000) Extended lymphnode dissection in gastric cancer: Standard, selective or unnecessary procedure? Hepatogastroenterology 47:904-906
29. Seto Y, Nagawa H, Muto T (1997) Results of extended lymph node dissection for gastric cancer with N2 lymph node metastasis. Int Surg 82:257-261
30. Fuji M, Sasaki J, Nakajima T (1999) State of the treatment of gastric cancer: From the 71st Japanese Gastric Cancer Congress. Gastric Cancer 2:151-157